0000905718-18-000109.txt : 20180205 0000905718-18-000109.hdr.sgml : 20180205 20180205155423 ACCESSION NUMBER: 0000905718-18-000109 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180205 DATE AS OF CHANGE: 20180205 EFFECTIVENESS DATE: 20180205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Variant Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001613083 IRS NUMBER: 465188564 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-304829 FILM NUMBER: 18574154 BUSINESS ADDRESS: STREET 1: 2200 N. COMMERCE PARKWAY STREET 2: SUITE 200 CITY: WESTON STATE: FL ZIP: 33326 BUSINESS PHONE: 954-931-2075 MAIL ADDRESS: STREET 1: 2200 N. COMMERCE PARKWAY STREET 2: SUITE 200 CITY: WESTON STATE: FL ZIP: 33326 D 1 primary_doc.xml X0708 D LIVE 0001613083 Variant Pharmaceuticals, Inc. 2200 N. COMMERCE PARKWAY SUITE 200 WESTON FL FLORIDA 33326 954-931-2075 FLORIDA None None Corporation true 2014 Stephen C Glover 2200 N. COMMERCE PARKWAY SUITE 200 WESTON FL FLORIDA 33326 Executive Officer Director Aaron Greenblatt 2200 N. COMMERCE PARKWAY SUITE 200 WESTON FL FLORIDA 33326 Director Jules Musing 2200 N. COMMERCE PARKWAY SUITE 200 WESTON FL FLORIDA 33326 Director Pharmaceuticals Decline to Disclose 06b false 2018-01-19 false true false 0 1651669 1403627 248042 Conversion of existing promissory notes only. false 20 0 0 0 true false Variant Pharmaceuticals, Inc. /s/ Stephen C. Glover Stephen C. Glover CEO 2018-02-05